Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (165)	5/23/2001 10:47:55 AM
From: Ian@SI	Read Replies (1) \| Respond to of 824

Well it's a month later, but the insider buying at ALXN got an honourable mention in this morning's WSJ... interactive.wsj.com May 23, 2001 Inside Track Executives Buy Shares At Small-Biotech Firms By CASSELL BRYAN-LOW Staff Reporter of THE WALL STREET JOURNAL Corporate executives and directors of some smaller biotechnology and drug-development companies recently have been buying their own company shares. ... Companies where insiders have recently been buying shares include drug-development concerns Trimeris Inc., and Alexion Pharmaceuticals Inc., as well as Medicines Co., which acquires and wins approval for drugs in late stages of development. ...